News | March 25, 2014

Aerotel Receives CE Mark Approval for Its New ECG Devices, HeartView P12/8i and HeartView 12L


March 25, 2014 — Aerotel Medical Systems has received the CE Mark approval for its new electrocardiogram (ECG) devices, HeartView P12/8i and HeartView 12L.

The HeartView 12L, a high-resolution 12-lead ECG recorder and transmitter for professional use is one of the world's smallest and most powerful ECG monitors. The new HeartView P12/8i, an ECG event recorder-transmitter for personal use, is a powerful ECG device with high-resolution 12-lead ECG recording technology, specifically designed for patient use.

Both devices enable the transmission of comprehensive ECG data from any place at any time. The recorded ECG is transmitted automatically via Bluetooth to Aerotel's Mobile CliniQ App. The ECG data is then automatically sent from the mobile device to a cardiac call center for immediate diagnosis.

The HeartView devices allow:

  • Diagnosis of cardiac symptoms
  • Remote monitoring of chronic heart patients
  • Recording and transmission of an ECG to a cardiac call center
  • Cardiac analysis for clinical studies

For more information: www.aerotel.com


Related Content

Feature | ECG | Samir Awasthi, MD, PhD

For decades, medicine has treated the electrocardiogram as a familiar, inexpensive and indispensable test, but also as ...

Home June 16, 2026
Home
News | ECG

June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform ...

Home June 05, 2026
Home
News | ECG

June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...

Home June 02, 2026
Home
News | ECG

May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...

Home May 08, 2026
Home
News | ECG

April 15, 2026 – AliveCor has received CE Mark (Conformité Européenne) for the Kardia 12L electrocardiogram (ECG) System ...

Home April 15, 2026
Home
News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
Subscribe Now